In the case of IKZF1-related CID, lymphocyte phenotyping (i.e., abnormal T lymphocytes with intermediate CD45RA expression and CD31+) as second tier or primary diagnostics could be a valuable tool in identifying these patients. This evidence concerns the gene IKZF1 and combined immunodeficiency.